Risk Factors for Survival in Children with Refractory AML Treated According to AML Relapse Strategies
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- IDA-FLAG (Idarubicin, Fludarabin, hochdosiertes Cytarabin und G-CSF) - Ein effektives Therapieschema in der Behandlung von AML-Rezidiven bei Kindern und JugendlichenKlinische Padiatrie, 1996
- Treatment of Patients with Acute Myelogenous LeukemiaJournal of Pediatric Hematology/Oncology, 1995
- Rezidivbehandlung bei akuter myeloischer Leukämie im KindesalterKlinische Padiatrie, 1992
- Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study GroupBlood, 1990
- In vitro chemosensitivity testing of leukemic cells: Prediction of response to chemotherapy in patients with acute non-lymphocytic leukemiaHematological Oncology, 1989
- Stratification by stepwise regression, correspondence analysis and recursive partition: a comparison of three methods of analysis for survival data with covariatesComputational Statistics & Data Analysis, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958